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Abstract
Even though model predictive control (MPC) is
currently the main algorithm for insulin control
in the artificial pancreas (AP), it usually requires
complex online optimizations, which are infea-
sible for resource-constrained medical devices.
MPC also typically relies on state estimation, an
error-prone process. In this paper, we introduce
a novel approach to AP control that uses Imita-
tion Learning to synthesize neural-network in-
sulin policies from MPC-computed demonstra-
tions. Such policies are computationally efficient
and, by instrumenting MPC at training time with
full state information, they can directly map mea-
surements into optimal therapy decisions, thus
bypassing state estimation. We apply Bayesian in-
ference via Monte Carlo Dropout to learn policies,
which allows us to quantify prediction uncertainty
and thereby derive safer therapy decisions. We
show that our control policies trained under a spe-
cific patient model readily generalize (in terms of
model parameters and disturbance distributions)
to patient cohorts, consistently outperforming tra-
ditional MPC with state estimation.
1. Introduction
The artificial pancreas (AP) is a system for the automated
delivery of insulin therapy for Type 1 diabetes (T1D), a dis-
ease in which patients produce little or no insulin to regulate
their blood glucose (BG) levels and maintain adequate glu-
cose uptake in muscle and adipose tissue. The AP consists
of an insulin infusion pump, and a subcutaneous Continuous
Glucose Monitor (CGM) for sensing glucose levels. CGM
readings are transmitted to a control algorithm that computes
the appropriate insulin dose. Such control should maintain
a fine balance. Lack of insulin leads to hyperglycemia (i.e.,
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high BG), which, if untreated, can cause complications such
as stroke, kidney failure, and blindness. Excessive insulin
can lead to hypoglycemia (low BG), a critical state which
can result in unconsciousness and death.
Driven by advances in the mathematical modeling of T1D
physiology (Hovorka et al., 2004; Man et al., 2014), Model
Predictive Control (MPC) (Camacho & Alba, 2013) has
become the gold-standard AP algorithm. MPC works by
determining the insulin therapy that optimizes the future BG
profile, predicted via physiological models. MPC, however,
has two important limitations. First, it requires complex
(often nonlinear and nonconvex) online optimization, which
is infeasible when the algorithm is deployed in resource-
constrained medical devices. This is why commercial AP
systems either use simplistic linear models within MPC1
or do not employ MPC at all in favor of simpler control
algorithms (e.g., PID control in the Medtronic™ Minimed
670G (Steil, 2013), or fuzzy logic in the Glucositter by
DreaMed Diabetes (Atlas et al., 2010)).
Second, and most crucial, MPC requires state estimation
(SE) to recover the most recent patient state from CGM
measurements (Gondhalekar et al., 2014; Paoletti et al.,
2019). Besides its computational cost, SE is error-prone, as
it relies strictly on CGM readings, which are an approximate,
delayed, and noisy proxy of the target control variable, the
BG. Incorrect state estimates might compromise the safety
of the insulin therapy.
Our Contributions. We present a novel method to derive
end-to-end insulin control policies, i.e., policies that sub-
sume state estimation and control, directly mapping CGM
measurements into patient-optimal insulin dosages. To cap-
ture the complex logic of MPC and SE, we consider policies
represented as Deep Neural Networks, LSTMs in particu-
lar (Hochreiter & Schmidhuber, 1997). Such an approach
addresses the main issues surrounding the use of MPC, as it
bypasses explicit SE and avoids the cost of MPC’s online
optimizations.
Our approach is centered around the use of Imitation Learn-
ing (IL) (Ross et al., 2011), where the control policy is
1The algorithm of Typezeror (Forlenza et al., 2019) uses a
linearized version of the nonlinear model of (Man et al., 2014).
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trained on examples provided by an MPC-guided teacher
policy. Building on the PLATO framework (Kahn et al.,
2017), at training time, we instrument the MPC teacher
to access the full state of the patient model. As such, the
learner policy, using only CGM measurements, will learn
to mimic MPC-based decisions, which are based on the
true model state and thus highly accurate. In this way, the
learned policy incorporates both SE and control.
We employ IL as it alleviates the covariate shift (Storkey,
2009) caused by the discrepancy between the training-time
state distribution (induced by the teacher policy) and the
test-time one (induced by the learner). Without IL, such a
distribution shift can lead to unpredictable behaviour of the
learner, and hence jeopardize the patient’s safety.
We learn our insulin policies via approximate Bayesian in-
ference, using Monte Carlo dropout (Gal & Ghahramani,
2016). The resulting stochastic policy can capture model
(epistemic) uncertainty, as well as uncertainty in the data,
due to, e.g., noisy measurements (Gal, 2016). Uncertainty
quantification is key in safety-critical domains like ours, and
is not addressed in the PLATO framework. Variations in
the patient’s behavior and in physiological dynamics are
indeed the norm, and can greatly affect the performance of
a deterministic policy, with health consequences for the pa-
tient. In contrast, in a Bayesian framework, such variations
likely yield high predictive uncertainty, information that we
actively use to make robust therapy decisions.
In summary, the main contribution of this paper is an Imita-
tion Learning-based method for deriving Bayesian neural
network policies for AP control, a method that overcomes
the two main shortcomings of established MPC-based ap-
proaches, namely, SE errors and computational cost. We em-
pirically show that: 1) our IL-based approach outperforms
Supervised Learning, and with less supervision data; 2) the
learned stochastic policies outperform MPC with SE and
deterministic policies; 3) our stochastic policies generalize
to never-before-seen disturbance distributions and patient
parameters that arise in a virtual patient cohort, while in the
same setting, MPC with SE show consistent performance
degradation. Overall, our best stochastic policy keeps BG
in the safe range 8.4%–11.75% longer than MPC with SE
and 2.94%–9.07% longer than the deterministic policy.
2. Background on MPC for the AP
We consider an in silico AP system, where the T1D pa-
tient is represented by a differential-equation model of BG
and insulin metabolism, including absorption, excretion
and transport dynamics between different body compart-
ments. In particular, we chose the well-established model
of Hovorka et al. (2004), a nonlinear ODE model with 14
state variables. A diagram of the MPC-based AP system is
showed in Fig. 1 (a). The state-space description is given in
equations (1–3) below. The notation ai,...,i+j stands for the
indexed sequence ai, ai+1, . . . , ai+j .
xt+1 = Fλt (xt, ut, dt) , λt ∼ Λ(λ | t), dt ∼ D(d | t)
(1)
yt = h (xt) + t (2)
ut = pi
∗(xˆt, dt,...,t+Np) (3)
xˆt = g(yt−Nb,...,t, ut−Nb,...,t, dt−Nb,...,t−1) (4)
Equation (1) describes the T1D patient model, where xt is
the patient state at time t, ut is the insulin input, λt are the
patient parameters with distribution Λ(λ | t), and dt is the
meal disturbance (amount of ingested carbohydrate) with
distribution D(d | t). Note that both parameters and distur-
bances are random and time-dependent. Meal disturbances
indeed depend on the patient’s eating behaviour, which fol-
lows daily and weekly patterns. Similarly, parameters are
typically subject to intra-patient variations such as daily
oscillations. The parameter distribution Λ(λ | t) can be
alternatively defined to capture a population of patients (as
we do in the experiment of Section 6).
Variable yt is the observed output at time t, i.e., the CGM
measurement, which is subject to Gaussian sensor noise
t ∼ N (0, σ), as done in previous work (Soru et al., 2012;
Patek et al., 2007). With pi∗ we denote the MPC-based
control policy, that, given state estimate xˆt and future meal
disturbances dt,...,t+Np as inputs, with Np being the MPC
prediction horizon, computes the optimal insulin therapy by
solving, at each time t, the following online optimization
problem (Paoletti et al., 2017; 2019)2:
min
ut,...,t+Np−1
J(xˆt, dt,...,t+Np , ut,...,t+Np−1) =
Np∑
k=1
dBG(x˜t+k) + β ·
Nc−1∑
k=0
(∆ut+k)
2 (5)
subject to
ut+k ∈ Du, k = 0, . . . , Nc − 1 (6)
ut+k = u¯, k = Nc, . . . , Np − 1 (7)
x˜t = xˆt (8)
x˜t+k = Fλt+k(x˜t+k, ut+k, dt+k), k = 0, . . . , Np − 1
(9)
where Nc ≤ Np is the control horizon; Du is the set of
admissible insulin values; (7) states that u is fixed to the
basal insulin rate u¯ outside the control horizon. (8) and (9)
2At each time step, the solution is actually a sequence of Np
insulin values, of which we retain only the first one.
(a) (b)
Figure 1. a) A typical MPC-based AP system, where the controller
requires a state estimate. b) Our learned end-to-end insulin policy
instead only requires (noisy) observations.
describe how the predicted state x˜ evolves from estimated
state xˆt at time t following the plant model (1). The ob-
jective function contains two terms, the former designed to
penalize deviations between predicted and target BG (via
function dBG), the latter to avoid abrupt changes of the
insulin infusion rate. The coefficient β > 0 is a hyper-
parameter. See (Paoletti et al., 2017; 2019) for more details.
Note that in order to predict future BG profiles, MPC re-
quires some information of the future disturbances. In this
work, we assume that the true future disturbance values are
known. Alternative MPC formulations with weaker assump-
tions (Hughes et al., 2011; Paoletti et al., 2019) could be
considered alternatively.
Finally, (4) describes state estimation (performed by func-
tion g), which follows the so-called Moving Horizon Esti-
mation (MHE) method (Rawlings, 2013). MHE is the dual
of MPC in that MHE also uses model predictions but, this
time, to estimate the most likely state given a sequence of
Nb past measurements, control inputs, and disturbances.
The estimate is the state that minimizes the discrepancy
between observed CGM outputs and corresponding model
predictions. As such, the quality of the estimate directly
depends on the accuracy of the predictive model and the
quality of the measurements. Details of the MHE optimiza-
tion problem for the AP can be found in (Chen et al., 2019).
Alternative SE methods include Kalman filters and particle
filters (Rawlings, 2013), but these are subject to the same
kinds of estimation errors as MHE.
3. Overview of the Method
The main goal of our work is to design an end-to-end insulin
control policy for the AP, i.e., policies that directly map
noisy system outputs (CGM measurements) into an optimal
insulin therapy, without requiring knowledge of the system
state. The control loop of such a policy is illustrated in
Fig. 1 (b). To this purpose, we follow an imitation learning
approach where the learner policy is trained from examples
provided by an MPC-based expert, called the teacher policy.
Following the PLATO algorithm (Kahn et al., 2017), at
training time, the teacher is instrumented with full state
information, so that its demonstrations are not affected by
SE errors.
Figure 2. Overview of the IL scheme for the AP. Training-time
trajectories are generated by applying the adaptive teacher policy,
which is a trade-off between the optimal supervision policy and the
learner’s policy. For training the learner, visited states are labelled
with the optimal action of the supervision policy.
Supervised learning (SL) is not a viable solution to our prob-
lem because SL assumes i.i.d. training and test data, while
our case is subject to covariate shift: the training data follow
the distribution of trajectories visited through the teacher,
while at test time we have a different distribution, induced
by the learner policy. If the learner cannot imitate perfectly
the teacher, in the long-run the learner’s actions will bring
the system into a state far from the training distribution,
where the behaviour of the learner becomes unpredictable,
and with clear safety implications for our AP system. In
IL, the teacher should provide demonstrations on trajecto-
ries that the learner would explore, but without knowing
the learner in advance. To do so, a common solution is to
reduce IL into a sequence of SL problems, where at each
iteration, the learner is trained on the distribution induced
by the previous learners or by a “mixture” of learner and
teacher policies (Ross & Bagnell, 2010; Ross et al., 2011).
Our IL method builds on the PLATO algorithm for adaptive
trajectory optimization (Kahn et al., 2017). See Section 7
for a summary of our extensions to PLATO. PLATO also
reduces IL into a sequence of SL problems, where at each
iteration, the teacher’s actions gradually adapt to those of
the current learner policy. This adaptive teacher is an MPC-
based policy whose objective function is extended to match
the learner’s behaviour. As such, it is non-optimal, and is
only used to generate trajectories that approach the distribu-
tion induced by the learner, thereby alleviating the covariate
shift problem. The training data is obtained by labelling
the adaptive teacher trajectories with the original (optimal)
MPC policy. We call the latter supervision policy. The
training process is summarized in Fig. 2. In our approach
the learner policy is stochastic, represented as a Bayesian
neural network, as explained in Section 5.
4. Imitation Learning Algorithm
The supervision policy pi∗ is the MPC policy for the AP
system of (5–9). Its control action at time t, u∗t , is obtained
by running the MPC algorithm given the true system state
xt (instead of the estimated state) and future meal distur-
bances: u∗t = pi
∗(xt, dt...t+Np). The learner policy pi
L
θ is
represented by an LSTM network with parameters θ. The
choice of a recurrent architecture is natural for our applica-
tion, because our policies have to subsume both control and
SE and, as discussed in Section 2, SE for nonlinear models
can be seen as a sequence prediction problem, see (4).
At time t, the learner policy takes an input sequence, which
includes past observations y1,...,t, past and future distur-
bances dNp+1,...,t+Np , and past control actions u1,...,t−1,
and predicts the control action at time t, uLt , by iterating the
following equation:
st = fθ(st−1, ut−1, yt, dt+Np) (10)
uLt = gθ(st) (11)
piLθ = gθ ◦ fθ (12)
where st is the hidden state of the network at time t, and fθ
and gθ are activation functions. The learner results from the
composition of gθ and fθ. Since we use a stochastic policy
for piLθ (see Section 5), we will denote the learner by the
conditional distribution piLθ (u
L
t | st−1, ut−1, yt, dt+Np).
The adaptive teacher policy piT extends the supervision
policy pi∗ with a term to penalize the mismatch between the
supervision policy, i.e., the optimal MPC policy, and the
learner. The output uTt of pi
T is the first control action in
the solution of the following MPC problem.
min
uTt,...,t+Np−1
J(xt, dt,...,t+Np , u
T
t,...,t+Np−1) + ρ · JM
(13)subject to (6–9).
The first term of (13) is the cost function of the supervision
policy (5). The second term penalizes the distance between
the optimal (supervision) control action and the action that
the learner policy would perform. The factor ρ determines
the relative importance of matching the behavior of the
learner policy piLθ against minimizing the cost J . In our
experiments, we set ρ = 1− 0.8i−1 where i is the iteration
of our IL algorithm, see Algorithm 1. In this way, the
relative importance of matching piLθ increases as the learner
improves (i.e., as i increases). By gradually matching the
behaviour of the learner, the control actions taken by piT
will lead to exploring a state space similar to the one induced
by the learner policy.
The distance term JM is defined as the p-th Wasserstein
distance Wp between the output distribution of the learner
policy piLθ (u
L
t | st−1, ut−1, yt, dt+Np) and the optimal con-
trol action uTt , or more precisely, the Dirac distribution
centered at uTt , δuTt . We choose Wp because the two dis-
tributions are likely to have disjoint supports, and so other
measures like the KL divergence (used in PLATO) are unde-
fined or infinite. As we will see, an analytical form for piLθ is
not available, but we can sample from it and obtain the em-
pirical approximation 1n
∑n
i=1 δuLt,i , where u
L
t,1, · · · , uLt,n
are the sampled values of piLθ . Thus, we have that
JM = Wp
(
δuTt ,
1
n
n∑
i=1
δuLt,i
)
=
(
1
n
n∑
i=1
d(uLt,i, u
T
t )
p
)1/p
,
(14)
where d is a suitable distance. Note that the above equality
holds as we are comparing a discrete distribution with a
Dirac distribution. We set p = 1 and d(·) = ‖ · ‖2.
Algorithm 1 outlines our IL scheme, which consists of a
sequence ofN SL iterations. The learner policy is initialized
at random. At each iteration, we start from a random initial
state of the plant and generate a trajectory of the system of
length Te. To do so, we first sample a sequence of random
meal disturbances, i.e., of ingested carbohydrates (lines
5-7). Then, for each time point t of the trajectory, the
adaptive teacher piT computes an insulin infusion rate uTt
by solving (13), that is, by optimizing the MPC objective
while matching the current learner policy piLθi (line 11). The
MPC supervision policy pi∗ is used to compute the optimal
control action u∗t by solving (5) (line 12). The optimal
action is used to label the corresponding training example(
(yt, u
T
t−1, dt+Np), u
∗
t
)
, which is added to the training set
S (line 13), while the sub-optimal action by the adaptive
teacher is used to evolve the system state (line 14). At the
end of each iteration, piLθi is trained using the current set of
examples S. As the teacher gradually matches the learner,
the training-time distribution of the system state gradually
approximates that at test time.
The time complexity of Algorithm 1 is dominated by the two
MPC instances (lines 11 and 12), which are solved N · Te
times, and the training of the learner piL, repeated N times.
5. Bayesian inference of control policy
We take a Bayesian approach to learn our control policy,
which results in a stochastic policy represented by a neural
network with fixed architecture and random parameters θ.
This provides us with a distribution of policy actions, the
predictive distribution, from which we can derive uncer-
tainty measures to inform the final therapy decision. Such
uncertainty should capture both data uncertainty, due to e.g.,
noisy measurements, and epistemic uncertainty, i.e., the lack
of confidence of the model about a given input (Gal, 2016).
Performing Bayesian inference corresponds, given training
data S, to computing the posterior p(θ | S) from some prior
p(θ) by applying Bayes rule. The distribution of policies
is induced by the random parameters θ ∼ p(θ | S). In
particular, the predictive distribution p(uLt | x, S), with x =
Algorithm 1 IL for Artificial Pancreas control policy using
adaptive trajectory optimization
1: Initialize training dataset S ← ∅.
2: Randomly initialize learner policy piLθ1 .
3: Sample random patient parameters λ ∼ Λ(λ | t)
4: for i = 1 to N do
5: for t = 1 to Te +Np do
6: Sample random carb disturbance dt ∼ D(d | t)
7: end for
8: Initialize the patient state x1.
9: for t = 1 to Te do
10: Collect CGM measurements yt as per (2)
11: Compute sub-optimal therapy with adaptive
teacher: uTt ∼ piT (uTt | xt, dt,··· ,t+Np , piLθi).
12: Compute optimal therapy with supervision policy:
u∗t = pi
∗(xt, dt,··· ,t+Np).
13: Append
(
(yt, u
T
t−1, dt+Np), u
∗
t
)
to S.
14: State evolves as xt+1 = Fλ
(
xt, u
T
t , dt
)
15: end for
16: Train piLθi+1 on S
17: end for
(st−1, ut−1, yt, dt+Np) being the policy inputs, is obtained
from p(θ | S) as:
p(uLt | x, S) =
∫
piLθ (u
L
t | x) · p(θ | S) dθ. (15)
For the non-linearity of the neural network function, pre-
cise inference is, however, infeasible and thus one needs to
resort to approximate methods (Neal et al., 2011; Blundell
et al., 2015). Monte Carlo Dropout (MCD) (Gal & Ghahra-
mani, 2016) is one of these. Dropout is a well-established
regularization technique based on dropping some neurons
at random during training with some probability p. Tech-
nically, this corresponds to multiplying the weights with
a dropout mask, i.e., a vector of Bernoulli variables with
parameter p. Then, at test time, standard dropout derives
a deterministic network by scaling back the weights by a
factor of 1/(1 − p). On the other hand, in MCD the ran-
dom dropout mask is applied at test time too, resulting in
a distribution of network parameters. Gal & Ghahramani
(2016) show that applying dropout to each weight layer is
equivalent to performing approximate Bayesian inference
of the neural network. This property is very appealing as
it reduces the problem of inferring p(θ | S) to drawing
Bernoulli samples, which is very efficient.
Sample size. For the empirical approximation of (15), we
choose a sample size of n = 47 that, by the Dvoretzky-
Kiefer-Wolfowitz inequality (Massart, 1990), gives us the
following statistical guarantee:
Pr
(
sup
x∈R
|Fn(x)− F (x)| > 0.2
)
< 0.05,
where F is the CDF of the predictive distribution and Fn its
empirical approximation with n = 47 observations.
Decision rule. The output of our policy is the distribution
of insulin actions (15). Hence, we need to define a decision
rule that produces an individual value ut out of this distri-
bution, and we want such rule to account for the predictive
uncertainty of the policy. Let uLt,1, · · · , uLt,n be the ordered
empirical sample of (15), and let yt−1 be the last measured
glucose value. Our rule selects a particular order statistic
uLt,M , i.e., one of the sampled values, depending on the rela-
tive distance of yt−1 w.r.t. the safe BG upper bound BGub
and lower bound BGlb. We call this adaptive rule because
the selected order statistic is adapted on yt−1. Formally,
ut = uLt,M ,with M = n·d(yt−1−BGlb)/(BGub−BGlb)e.
(16)
In this way, if the patient is approaching hypoglycemia (yt−1
close to BGlb), we select a conservative insulin value, and
we select instead an aggressive therapy if yt−1 is close to
hyperglycemia (BGub). Importantly, as the policy uncer-
tainty increases (and so does the spread of the sample), ut
gets more conservative when yt−1 is in the lower half of the
safe BG range, i.e., we take safer decisions when the policy
is less trustworthy3. For the same principle, when yt−1 is in
the upper half of the range, higher uncertainty yields a more
aggressive therapy, but this poses no safety threats because
yt−1 is well away from the hypoglycemia threshold BGlb.
In our evaluation, we compare our adaptive rule with the
commonly used rule that sets ut to the sample mean of (15).
6. Experiments
We conducted computational experiments to validate the
following claims:
1. Our IL-based approach outperforms SL, and with less
supervision data.
2. The learned stochastic policies outperform both MPC
with SE and deterministic policies.
3. The stochastic policies generalize well to unseen pa-
tient physiological parameters and meal disturbances.
4. For a stochastic policy, the adaptive decision rule (16)
outperforms the mean prediction rule.
5. The predictive uncertainty of the policy increases with
out-of-distribution test inputs.
Runtime cost. On our workstation4 the stochastic policy
executes in approximately 20 milliseconds, which is well
3Protecting against hypoglycemia is the primary concern.
4With an Intel i7-8750H CPU and 16GB DDR4 SDRAM
within the CGM measurement period of 5 minutes, and
consistently more efficient than MPC-based optimization
(on average, 150+ times faster in our experiments)5. Thanks
to platforms such as TensorFlow Lite, we believe that a
similar runtime can be obtained also after deploying the
policy on embedded hardware.
LSTM architecture. We represent the learner policy as
an LSTM network with three layers, of 200 hidden units
each, with tanh state activation functions and sigmod
gate activation functions. The network has a fully connected
layer, a ReLu activation function layer and a regression
layer as final layers. We added a dropout layer before each
weight layer with dropout probability 0.2, which empirically
gave us the best accuracy among other probability values.
We also experimented with feedforward architectures but
these performed poorly, confirming the need for a recurrent
architecture to adequately represent SE and control.
Performance measures. To evaluate and compare the in-
sulin policies, we consider three typical performance mea-
sures in the AP domain: thypo, thyper, teu: the average per-
centage of time the virtual patient’s BG is in hypoglycemia
(i.e., BG ≤ 70 mg/dL), hyperglycemia (i.e., BG ≥ 180
mg/dL), and in the safe range, or euglycemia (i.e., 70 mg/dL
≤ BG ≤ 180 mg/dL), respectively. Given the goal of dia-
betes treatment and BG control, the target is to maximize
teu while minimizing thypo (hypoglycemia leads to more
serious consequences than hyperglycemia).
Experimental settings. During training, we consider a
fixed (and time-constant) parameterization of the T1D vir-
tual patient model, and the disturbance distribution of Ta-
ble 1 (which includes three large meals and three small
snacks). The length of each training trajectory is set to
Te = 1440. We performed N = 34 iterations of the IL
algorithm, totalling to a training set size of |S| = 48, 960.
At test time, we consider the following three configurations
of the model parameters:
1. Fixed Patient. The test-time virtual patient has the
same parameters as during training.
2. Varying Patient. We introduce intra-patient temporal
variations to the parameters.
3. Patient cohort. We introduce both inter-patient and
intra-patient variations. The distribution of model pa-
rameters represents a cohort of virtual patients, where
each patient has time-varying parameters. It might in-
clude severe cases when the parameters are sampled at
marginal areas of the distribution.
5Optimization for MPC and SE is solved used MATLAB’s im-
plementation of the interior-point algorithm of Byrd et al. (2000).
The above distributions for modelling intra- and inter-patient
variability are taken from (Wilinska et al., 2010), where the
authors derived them from clinical data.
For each configuration and policy, we simulate 90 trajecto-
ries of a one-day simulation. For each trajectory, we draw
a fresh observation of the random disturbance and patient
parameters, but, to ensure a fair comparison, these are kept
the same for all control algorithms.
In another set of experiments, we consider (in combination
with the above configurations) a meal disturbance distri-
bution different from the one at training time. This meal
distribution reflects a late eating habit and a larger probabil-
ity of larger snacks, which leads to meal profiles with higher
carbs. Further details are reported in the supplement.
For each experiment, we evaluate the performance of the
following policies:
• MPC+SI: the supervision policy pi∗, i.e., the MPC
algorithm with full information on the current state and
model parameters. We stress that full observability is
an unrealistic assumption, yet useful to establish an
ideal performance level. We set control and prediction
horizons of MPC toNc = 100 min andNp = 150 min,
respectively.
• MPC+SE: the MPC algorithm with state estimation,
as described in (5–9). This is one of the most common
control schemes for the AP. The parameters of the T1D
model used within MPC and SE are set to the training-
time values. We will show that SE takes a toll on the
overall performance, unlike our end-to-end policies.
• DLP: the deterministic learner policy, where dropout
is used at training time but not at test time.
• SLP-M: the stochastic learner policy with the rule that
selects the sample mean of the predictive distribution.
• SLP-A: the stochastic learner policy with the adap-
tive rule of (16). As explained above, such rule ac-
tively uses uncertainty information by selecting an
order statistic of the predictive distribution commen-
surate to the sensed glucose. We will show that this
policy outperforms all the others (but MPC+SI).
IL outperforms SL. We compared the performance of
SLP-A, which is trained via the IL algorithm of Section 4,
against the corresponding stochastic policy trained using
an MPC-guided SL approach, that is, without the adaptive
teacher policy that guides the exploration of training trajec-
tories but only using the supervision policy.
We found that the IL-based policy has much better control
performance than the SL-based one, using the same number
(a) Fixed patient (b) Varying patient (c) Patient cohort
Figure 3. Mean BG ± standard deviation for MPC with state estimation vs stochastic policy with adaptive output.
Table 1. Attributes of meal disturbance distribution during training.
CHO amounts and starting times are sampled uniformly from the
reported intervals.
breakfast snack 1 lunch snack 2 dinner snack 3
Occurrence 100 50 100 50 100 50Probability (%)
CHO Amount 40-60 5-25 70-110 5-25 55-75 5-15(gram)
Time of 1:00- 5:00- 8:00- 12:00- 15:00- 19:00-
day (hour) 5:00 8:00 12:00 15:00 19:00 21:00
of algorithm iterations and training examples. This suggests
that the IL-based policy captures more useful state-action
information and that the IL algorithm leads the learner pol-
icy to efficiently explore the state space. In particular, after
20 iterations of Algorithm 1, SLP-A achieves an average of
79.60% for teu (time in range), while the SL-based coun-
terpart only 17.35%. IL consistently outperforms SL in all
other performance metrics too (see Appendix B for more
detailed results).
Stochastic policies outperform MPC with SE and deter-
ministic policies. Results in Table 2 evidence that the
stochastic policies (SLP-A and SLP-M) outperform the
MPC policy with state estimation in essentially all perfor-
mance measures and configurations, and in a statistically
significant manner. In particular, we observe that, on av-
erage, the SLP-A policy stays in range for 8.4%–11.75%
longer than MPC+SE, and the SLP-M does so for 5.97%–
8.4% longer. This is visible also from the BG profiles of
Figure 3. The deterministic policy also performs better than
MPC+SE, but lags behind the stochastic ones, with SLP-A
achieving a time in range 2.94%–9.07% longer than DLP.
These results suggests that MPC with SE introduces estima-
tion errors that have a detrimental effect on BG control, as
also confirmed by the fact that the same control algorithm
but with full state information (MPC+SI) is way superior.
In realistic settings where the true patient state is not acces-
sible, our analysis shows that an end-to-end policy is to be
preferred to explicit SE.
Stochastic policies generalize to unseen patient param-
eters and disturbances. From Table 2 and Figure 3, we
observe that our stochastic policies are robust to patient
parameters unseen during training, with a time in range
constantly above 85% for the varying patient and the pa-
tient cohort configurations. The superiority of the stochastic
policies over the deterministic one under intra-patient and
inter-patient variability evidence the role of considering
prediction uncertainty when the policy is deployed in envi-
ronments that deviate from the training one.
We further evaluate the robustness of the SLP-A policy un-
der an unseen meal disturbance distribution characterized by
a higher carbs intake. Results, reported in Table 3, evidence
that our stochastic policy generalize well also in this case.
A hypothesis test can be found in Appendix D, showing
that the performance statistics SLP-A achieves under intra-
patient and inter-patient variability with two different meal
distributions has no significant difference.
Adaptive rule outperforms mean-value rule. The SLP-
A policy obtains a time in range approximately 5% longer
than SLP-M in the fixed patient and varying patient con-
figurations, see Table 2. There is an improvement also in
the patient cohort experiment, albeit less significant. With
the adaptive rule, the policy adopts a more conservative or
aggressive therapy depending on the measured glucose and
the predictive uncertainty, which can lead to more stable BG
trajectories and explain the observed difference.
Policy uncertainty increases at out-of-distribution test
inputs. We verify that inference via Monte Carlo dropout
adequately captures epistemic uncertainty. We indeed ob-
serve an increased variability of the predictive distribution
in the patient cohort configuration, that is, when the pol-
icy is applied to out-of-distribution test data resulting from
introducing inter- and intra-patient variability. However,
uncertainty does not significantly increase from the first to
the second configuration, that is, when introducing only
inter-patient variability. These results were confirmed via
Table 2. Performance of MPC with state information (MPC+SI), MPC with state estimation (MPC+SE), deterministic learner policy
(DLP), stochastic learner policy with mean value output (SLP-M), and stochastic learner policy with adaptive output (SLP-A). For each
column, in bold are the significantly best policies, i.e., with p < 0.005 in all pairwise sign tests (one-sided) (Hollander et al., 2013). A
complete, detailed table of performance statistics and the processes of hypothesis tests can be found in Appendix A.
Fixed Patient Configuration Varying Patient Configuration Patient Cohort Configuration
thypo (%) teu (%) thyper (%) thypo (%) teu (%) thyper (%) thypo (%) teu (%) thyper (%)
MPC+SI 0.00 ± 0.00 99.84± 0.60 0.16± 0.60 0.00±0.00 99.80±0.83 0.20±0.83 0.00±0.00 99.15±1.81 0.85±1.81
MPC+SE 0.92±2.76 80.40±5.33 18.68±4.76 1.44±3.18 79.88±5.46 18.69±4.95 0.85±3.57 77.17±15.39 21.98±14.30
DLP 0.21±0.99 85.40±4.15 14.38±3.90 0.53±1.87 82.66±6.42 16.82±6.25 0.45±1.91 82.63±6.28 16.93±6.15
SLP-M 0.23±1.10 86.33±4.17 13.44±4.09 0.33±1.09 86.34±4.20 13.33±4.06 0.32±1.19 85.45±4.34 14.23±4.00
SLP-A 0.13±0.64 91.73±3.45 8.14±3.39 0.05±0.27 91.73±3.18 8.23±3.15 0.04±0.41 85.57±4.12 14.39±4.08
Table 3. Performance of SLP-A with unseen disturbances.
Performance Fixed Patient Varying Patient Patient Cohort
Metrics Configuration Configuration Configuration
thypo (%) 0.35± 1.08 0.67± 1.83 0.00± 0.00
teu (%) 91.41± 3.67 90.77± 4.44 85.92± 3.96
thyper (%) 8.24± 3.43 8.56± 3.73 14.08± 3.96
pair-wise two-sample Kolmogorov-Smirnov tests over the
coefficients of variation (CoVs), i.e., the mean-normalized
standard deviations (differences significant at p < 10−37).
See Appendix C for the elaboration on the Kolmogorov-
Smirnov tests and a plot of the CoVs distributions.
7. Related Work
Traditional methods for insulin control in the AP mostly
rely on MPC (Hovorka et al., 2004; Magni et al., 2007; Lee
et al., 2009; Cameron et al., 2011; Paoletti et al., 2019), PID
control (Steil et al., 2004; Huyett et al., 2015), and fuzzy
rules based on the reasoning of diabetes caregivers (Atlas
et al., 2010; Nimri et al., 2012). Reinforcement learning
approaches have been proposed as well, including policy it-
eration (De Paula et al., 2015; Weng et al., 2017), actor critic
methods (Daskalaki et al., 2016), and deep Q-networks for
dual-hormone therapy (Zhu et al., 2019)6. Neural networks
have been explored in the AP space not just to represent
insulin policies (de Canete et al., 2012; Zhu et al., 2019),
but also to predict BG concentration based on inputs such as
insulin dosage, nutritional intake, and daily activities (Pap-
pada et al., 2008; Pe´rez-Gandı´a et al., 2010; Dutta et al.,
2018; Li et al., 2019). Our work is different from the above
papers as: 1) it takes an imitation learning approach to
learn the insulin policy, mitigating potential (and dangerous)
6Dual-hormone therapy allows infusion of both insulin and
its antagonist hormone, glucagon, which protects against hypo-
glycemia. However, it is not as established as insulin-only therapy,
and still has safety concerns (Taleb et al., 2017).
test-time distribution drifts; 2) incorporates in the policy
uncertainty information obtained via Bayesian inference; 3)
it produces end-to-end policies that do not require learning
a separate BG prediction model.
Several imitation learning methods have been proposed,
such as (Daume´ et al., 2009; Ross & Bagnell, 2010; Ross
et al., 2010; Ho & Ermon, 2016). Some of these, like our
approach, are tailored to work with MPC teachers (Zhang
et al., 2016; Kahn et al., 2017; Amos et al., 2018; Lowrey
et al., 2019). Our method is also akin to (Cronrath et al.,
2018; Menda et al., 2017; Lee et al., 2019) where Bayesian
extensions of IL are presented to quantify the learner’s pre-
dictive uncertainty and better guide the queries to the teacher
policy. Other Bayesian approaches in policy learning in-
clude (Deisenroth & Rasmussen, 2011; Gal et al., 2016;
Polymenakos et al., 2019). “Frequentist” alternatives to
Bayesian uncertainty quantification also exist (Vovk et al.,
2005; Wang & Qiao, 2018; Papernot & McDaniel, 2018;
Bortolussi et al., 2019; Park et al., 2020).
Our work builds on the PLATO IL algorithm (Kahn et al.,
2017) and extends it in three main direction: 1) we consider
recurrent architectures, which are more suitable than feed-
forward ones (used in PLATO) to represent nonlinear state
estimation and control; 2) PLATO also derives stochastic
policies but, unlike our work, no uncertainty-aware decision-
making strategies are considered; 3) PLATO policies do not
support systems with external disturbances beyond noise. In
our policies instead, random meal disturbances are central.
8. Conclusion
We introduced a method based on MPC-guided Imitation
Learning and Bayesian inference to derive stochastic Neural
Network policies for insulin control in an artificial pancreas.
Our policies are end-to-end in that they directly map CGM
values into insulin control actions. By using Bayesian neural
networks, we can crucially quantify prediction uncertainty,
information that we incorporate in the insulin therapy de-
cisions. We empirically demonstrated that our stochastic
insulin policies outperform traditional MPC with explicit
state estimation and are more robust than their deterministic
counterparts, as they generalize well to unseen T1D patient
parameters and meal disturbance distributions.
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Appendix
A. Significance Tests Details
Detailed statistics for all control policies and all configura-
tions are available in Table 4. We show extra performance
measures in this table: BGmax and BGmin, average of
maximum and minimum of BG values (in mg/dL); u, av-
erage insulin infusion rate (in mU/min). We performed
significance tests out of the collected data to validate our hy-
potheses regarding the performance of the learned stochastic
policies. Details are given below.
A.1. Hypotheses Formulation
We define our null and alternative hypotheses in the fol-
lowing for each of the performance measures: thypo, teu,
thyper, BGmax, BGmin and u.
• Null hypothesis H0 : µx−y = 0. The median of the
distribution of the difference of a specific performance
metric from two sets of experiments regulated by two
control policies is zero. Note the hypothesis of zero
median of x − y is not equivalent to a hypothesis of
equal median of x and y.
• Alternative hypothesisHA : µx−y > 0. The median of
distribution of the differences of a specific performance
metric from two sets of experiments regulated by two
control policies is larger (smaller) than zero.
This formulation is for a paired significance test, which
is suitable when comparing, like we do, experimental re-
sults about same configuration (and hence, same sampled
parameters and disturbances) but different policies.
A.2. Calculating statistic tests
For each combination of the compared policies, we use
sign tests to test the hypothesis that medians of distribution
of the difference between their thypo, thyper and BGmax
are larger than zero, and medians of distribution of the
difference between their teu, BGmin and u are smaller than
zero. In the main paper, we set the significance level to
α = 0.005 (i.e., 99.5% confidence).
A.3. Conclusion about H0
We can see the tests reject H0 when comparing teu and
thyper between SLP-A and all other policies, indicating
they are statistical significant larger (smaller) when a fixed
or varying patient is regulated by SLP-A than those by
other policies. The p-values of the sign test on BGmax also
support that SLP-A can significantly reduce hyperglycemia
for a fixed or varying patient compared to all others.
In a patient cohort, the null hypothesis cannot be rejected for
metrics teu and thyper when comparing SLP-A VS SLP-M,
indicating there is no significant difference in using these
two stochastic policies. However, when comparing these
two policies with any other policies, the null is rejected for
both teu and thyper. We can conclude that SLP-A and SLP-
M significantly reduce hyperglycemia while maintaining
short time in hypoglycemia.
B. Comparison Between Supervised Learning
and Imitation Learning
B.1. Performance improvement
Figure 4 (a) show the proportion of time blood glucose is in
every state (eu-, hyper- and hypo-glycemia) at each training
iterations using supervised learning, which improves much
slower than Figure 4 (b).
We can see the learner policy trained by IL outperforms it by
SL in reducing hypo-/hyper-glycemia and keeping patients’
blood glucose in healthy range (euglycemia). The mean of
maximum blood glucose decreases faster while the mean
of minimum blood glucose increases to prevent dangerous
hypoglycemia when SLP-A is trained by IL methods.
Figure 5 is the root mean squared error (RMSE) of both
learning methods at each training iteration. As we can see
from the curves, the training RMSE for SL and IL goes down
as the number of training episodes increases. The RMSE of
IL starts larger but decrease dramatically especially after the
first few episodes. Although the RMSE is smaller, stochastic
learner policy trained by SL methods has a limited training
state space and the out-of-distribution disturbance leads to
slow learning process from supervision (i.e., MPC controller
with perfect state information).
C. Uncertainty Analysis of Stochastic Learner
Policy
In our machine learning model for the stochastic learner
policy, we quantify the uncertainty of our predictive action.
Quantifying the uncertainty is critical in real-world settings
such as artificial pancreas (AP) system, in which often in-
volve out-of-distribution disturbance and patient variations.
We analyze the uncertainty quantifying ability of our Monte-
Carlo Dropout Bayesian method to investigate the effect of
covariate shift and virtual patient model variation.
C.1. Coefficients of variation
The coefficients of variation (CV), aslo known as relative
standard deviation, is defined as the division of the standard
deviation and the mean.
Table 4. Full statistics of the experiments in which virtual T1D patient(s) are regulated by the different controllers/control policies
Configuration thypo (%) teu (%) thyper (%) BGmax (mg/dL) BGmin(mg/dL) u (mU/min)
MPC+SI
Fixed Patient 0.00 + 0.00 99.84+ 0.60 0.16+ 0.60 181.28+13.64 123.40+3.85 28.11+0.95
Varying Patient 0.00+0.00 99.80+0.83 0.20+0.83 181.55+12.72 123.40+4.68 28.17+1.05
Patient Cohort 0.00+0.00 99.15+1.81 0.85+1.81 184.56+18.06 115.82+9.68 20.74+4.62
MPC+SE
Fixed Patient 0.92+2.76 80.40+5.33 18.68+4.76 242.68+12.84 84.87+14.68 27.98+1.17
Varying Patient 1.44+3.18 79.88+5.46 18.69+4.95 239.79+12.22 81.44+14.80 28.16+1.05
Patient Cohort 0.85+3.57 77.17+15.39 21.98+14.30 241.17+32.43 95.45+21.73 20.55+6.52
DLP
Fixed Patient 0.32+1.19 85.45+4.34 14.23+4.00 232.63+10.49 80.98+9.22 27.79+0.78
Varying Patient 0.53+1.87 82.66+6.42 16.82+6.25 225.66+10.40 82.27+10.91 28.59+0.76
Patient Cohort 0.45+1.91 82.63+6.28 16.93+6.15 225.58+10.41 83.14+10.95 28.59+0.79
SLP-M
Fixed Patient 0.28+0.99 86.33+4.17 13.44+4.09 230.41+10.27 81.20+9.31 28.39+0.75
Varying Patient 0.33+1.09 86.34+4.20 13.33+4.06 230.16+10.37 81.01+9.77 28.38+0.73
Patient Cohort 0.21+0.99 85.40+4.15 14.38+3.90 232.72+10.27 81.13+8.98 28.39+0.72
SLP-A
Fixed Patient 0.13+0.64 91.73+3.45 8.14+3.39 216.65+8.05 82.42+7.86 29.01+0.67
Varying Patient 0.05+0.27 91.73+3.18 8.23+3.15 216.98+7.68 82.50+8.35 28.97+0.69
Patient Cohort 0.04+0.41 85.57+4.12 14.39+4.08 232.02+8.92 86.84+9.58 28.61+0.73
Table 5. P values of the significance tests for all combinations of compared policies. In each column, the alternative hypothesis is the
medians of the observations is larger than zero of the difference in the metrics (i.e., observations from the first policy minus those from the
second) in the categories 1) thypo, 2)thyper and 3) BGmax, and is smaller than zero in the rest.
Configuration MPC+SE vs SLP-A DLP vs SLP-A SLP-M vs SLP-A MPC+SE vs DLP MPC+SE vs SLP-M DLP vs SLP-M
Fixed Patient
thypo 5.9090e-03 5.0000e-01 5.0000e-01 2.0695e-02 1.3302e-02 5.0000e-01
teu 3.7664e-20 7.1194e-20 3.8869e-14 6.2463e-07 2.1929e-10 4.2922e-11
thyper 3.7664e-20 1.3449e-19 2.6012e-13 1.8975e-06 9.7412e-10 1.3568e-12
BGmax 9.8208e-23 6.5759e-18 6.3970e-16 2.0826e-03 5.4510e-06 5.6818e-08
BGmin 8.2858e-01 5.4194e-01 7.0079e-01 9.1488e-01 9.7770e-01 2.9921e-01
u 1.0000e+00 1.0000e+00 1.0000e+00 9.9897e-01 9.9897e-01 6.2398e-01
Varying Patient
thypo 2.4617e-05 5.8594e-03 4.6143e-02 1.4725e-02 6.2705e-03 5.8810e-01
teu 2.1623e-21 6.3970e-16 5.4061e-19 5.6672e-02 3.6187e-10 3.8285e-05
thyper 5.4061e-19 5.2608e-15 5.4061e-19 8.5121e-02 2.9933e-07 9.3878e-05
BGmax 3.7664e-20 4.0354e-09 3.8869e-14 9.7412e-10 6.2463e-07 9.9598e-01
BGmin 5.4194e-01 5.6672e-02 1.7142e-01 3.7602e-01 6.2398e-01 5.4194e-01
u 1.0000e+00 9.9991e-01 1.0000e+00 9.9257e-01 9.9598e-01 2.2299e-02
Patient Cohort
thypo 1.9531e-02 3.5156e-02 1.0742e-02 2.9053e-01 6.8547e-01 7.7275e-01
teu 1.0301e-03 6.6763e-04 4.5806e-01 1.2305e-01 2.1896e-04 4.0230e-03
thyper 1.0301e-03 2.7725e-03 6.2398e-01 1.2305e-01 2.1896e-04 1.0301e-03
BGmax 1.2305e-01 9.9792e-01 3.7602e-01 1.3151e-02 3.7602e-01 9.9999e-01
BGmin 9.9999e-01 7.4334e-03 2.0826e-03 9.9996e-01 9.9999e-01 7.0079e-01
u 1.0000e+00 7.6960e-01 9.1488e-01 1.0000e+00 1.0000e+00 4.0230e-03
(a) Supervised Learning (b) Imitation Learning
Figure 4. Mean BG ± standard deviation on hypoglycemia, euglycemia, hyperglycemia for SLP-A trained by supervised learning v.s.
imitation learning. Imitation learning methods explore the state space whose distribution that has a small distance to that in test time, so
the SLP-A improves faster with IL-based methods.
Figure 5. RSME of SL and IL at each training iteration.
Figure 6 is the cumulative distribution functions (CDF) of
the CV of the stochastic learner policy outputs when the
learner policy is the control algorithm of an AP system
under three patient configuration as illustrated in Section 6
of our paper. The curve of patient cohort experiments is the
slowest to reach a probability of 1, and the curve of the fixed
patient experiments is the fastest but the curve of varying
patient experiment is close. We remark that, in this case, a
faster growing CDF implies a higher probability of smaller
CV values.
C.2. Kolmogorov-Smirnov test
In statistics, the Kolmogrov-Smirnov test, also known as
K-S test, tests null hypothesis for the equality of two proba-
bility distributions, or a sample distribution with a reference
probability distribution.
We use K-S test to quantify the distance between the empir-
Figure 6. CDFs of Coefficients of variations of the stochastic
learner policy outputs under three different patient configuration.
The uncertainty of the patient model caused by intra-/inter-patient
parameters variations is the largest in a patient cohort and smallest
in a fixed virtual patient.
ical CDF of the CV of SLP-A outputs under three patient
configurations with significance level α = 0.05. The null
hypotheses are rejected when compare the empirical CDF
of CV from patient cohort experiment and others in 5%
confidence level. Although the CDf curve of fixed patient
experiment is faster but the K-S test between it and the CDF
of varying patient experiment returns a decision that the
null hypothesis is accepted with p value 0.2453, thus they
are likely from the same CDF. The p values are believed
to be accurate since the sample sizes of the CDFs are large
enough, such that (n1 ∗ n2)/(n1 + n2)  4, with n1 and
n2 are the sample sizes of compared CDFs.
D. Generalization to different diet behaviors
The stochastic learner policy can not only generalize its
control ability onto different virtual patients but also to
different meal distributions.
D.1. Meal distribution
The attributes of the distinct meal distribution we used to
evaluate the generalization ability of our stochastic learner
policy is summarized in Table 6. The new distribution has a
higher probability of occurrence of snacks and larger snacks
with larger carbohydrate amounts. This describes a larger
system disturbance to the virtual patient models, and is more
challenging for our stochastic learner policy to regulate the
patients’ blood glucose level.
Table 6. Attributes of a different meal disturbance distribution dur-
ing testing to that during training. CHO amounts and starting times
are sampled uniformly from the reported intervals.
breakfast snack 1 lunch snack 2 dinner snack 3
Occurrence 100 80 100 80 100 80Probability (%)
CHO Amount 40-60 15-30 70-110 15-30 55-75 15-30(gram)
Time of 3:00- 7:00- 10:00 14:00 17:00 21:00
day (hour) 7:00 10:00 14:00 17:00 21:00 23:00
D.2. Performance
We also test our stochastic learner policy in three patient
configurations when the patients’ meals are subject to the
distribution in Table 6. The results of the performance are
shown in Table 7.
Table 7. The full performance of SLP-A with unseen disturbances.
Performance
Measures
Fixed Patient
Configuration
Varying Patient
Configuration
Patient Cohort
Configuration
thypo (%) 0.35±1.08 0.67±1.83 0.00±0.00
teu (%) 91.41±3.67 90.77±4.44 85.92±3.96
thyper (%) 8.24±3.43 8.56±3.73 14.08±3.96
BGmax (mg/dL) 218.25±8.05 217.03±6.70 233.22±10.48
BGmin(mg/dL) 76.52±6.02 76.15+6.70 87.69±9.30
u (mU/min) 29.26±0.75 29.32±0.74 28.70±0.67
D.3. Significance tests
We use above described sign test to evaluate, for each con-
figuration, if there are significant performance differences
when training-time VS never-before-seen disturbances are
used. The two sets of observations are from Table 7 and
those from SLP-A in Table 4. The p values of the statistical
tests are listed in Table 8.
We can observe that all p-values in the patient cohort exper-
Table 8. P values of sign tests for experiments with SLP-A under
trained meal distribution VS unseen meal distribution.
Performance
Metrics
Fixed Patient
Configuration
Varying Patient
Configuration
Patient Cohort
Configuration
thypo (%) 5.9235e-02 2.2125e-03 1.0000e+00
teu (%) 2.9921e-01 3.6275e-02 7.6960e-01
thyper (%) 4.5806e-01 2.3040e-01 7.0079e-01
BGmax (mg/dL) 3.7602e-01 5.4194e-01 4.5806e-01
BGmin(mg/dL) 5.6818e-08 1.4832e-05 8.2858e-01
u (mU/min) 2.2299e-02 2.2299e-02 2.9921e-01
iments are very high (the smallest is 0.29921), indicating
that, as expected, no significant performance difference is
observed in patient cohort: SLP-A is able to generalize its
control ability to an unseen meal distribution during train-
ing phase. In the other two patient configurations, the null
hypotheses are also accepted except thypo in the second
column and both BGmin.
